Compounds > podophyllotoxin
Page last updated: 2024-08-21

podophyllotoxin and Vascular Diseases

podophyllotoxin has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seiter, K1

Reviews

1 review(s) available for podophyllotoxin and Vascular Diseases

ArticleYear
Toxicity of the topoisomerase II inhibitors.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:2

    Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases

2005

Other Studies

1 other study(ies) available for podophyllotoxin and Vascular Diseases

ArticleYear
INFERIOR vena caval occlusion.
    The American journal of medicine, 1960, Volume: 28

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease; Doxorubicin; Female; Humans; Neoplasms; Podophyllotoxin; Pregnancy; Pregnancy Complications; Vascular Diseases; Veins; Vena Cava, Inferior; Vincristine

1960